View in EDS PDF Full Text

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.

Saved in:
Bibliographic Details
Title: Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
Authors: Binnenmars SH; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Hoogslag GE; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Yeung SMH; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Brouwers FP; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Bakker SJL; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., van Gilst WH; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Gansevoort RT; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Navis G; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands., Voors AA; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands., de Borst MH; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.
Source: Journal of the American Heart Association [J Am Heart Assoc] 2022 Aug 02; Vol. 11 (15), pp. e024952. Date of Electronic Publication: 2022 Jul 25.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35876420
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Binnenmars+SH%22">Binnenmars SH</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogslag+GE%22">Hoogslag GE</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Yeung+SMH%22">Yeung SMH</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brouwers+FP%22">Brouwers FP</searchLink>; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bakker+SJL%22">Bakker SJL</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Gilst+WH%22">van Gilst WH</searchLink>; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gansevoort+RT%22">Gansevoort RT</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Navis+G%22">Navis G</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Borst+MH%22">de Borst MH</searchLink>; Department of Internal Medicine, Division of Nephrology University of Groningen, University Medical Center Groningen Groningen The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580524%22">Journal of the American Heart Association</searchLink> [J Am Heart Assoc] 2022 Aug 02; Vol. 11 (15), pp. e024952. <i>Date of Electronic Publication: </i>2022 Jul 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101580524 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2047-9980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220479980%22">20479980 </searchLink><i>NLM ISO Abbreviation: </i>J Am Heart Assoc <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35876420
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1161/JAHA.121.024952
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e024952
    Titles:
      – TitleFull: Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Binnenmars SH
      – PersonEntity:
          Name:
            NameFull: Hoogslag GE
      – PersonEntity:
          Name:
            NameFull: Yeung SMH
      – PersonEntity:
          Name:
            NameFull: Brouwers FP
      – PersonEntity:
          Name:
            NameFull: Bakker SJL
      – PersonEntity:
          Name:
            NameFull: van Gilst WH
      – PersonEntity:
          Name:
            NameFull: Gansevoort RT
      – PersonEntity:
          Name:
            NameFull: Navis G
      – PersonEntity:
          Name:
            NameFull: Voors AA
      – PersonEntity:
          Name:
            NameFull: de Borst MH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 08
              Text: 2022 Aug 02
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2047-9980
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Journal of the American Heart Association
              Type: main
ResultId 1